” Even though the Ricaurte Tale was unfolding, MAPS ultimately acquired FDA indication-off over a protocol for human trials of MDMA for a procedure for PTSD, but only immediately after it procured a $one million insurance policies coverage to indemnify the review board.Various tablets could be taken at a single time or in succession more than a t